quinoxalines has been researched along with ascorbic acid in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Mokhtar, HM | 1 |
| Giurgea, R; Ioaniciu, D; Suteu, I | 1 |
| Borsa, M; Giurgea, R; Ilyés, I | 1 |
| Pond, WG; Yen, JT | 2 |
| Cross, RF; Moorhead, PD | 1 |
| Chetkovich, DM; Sweatt, JD | 1 |
| Arkhipenko, IuV; Durnev, AD; Guseva, NV; Lisitsina, TA; Sazontova, TG | 1 |
| Efimov, IuV; Sychugov, AV; Zaĭtsev, VG | 1 |
| Kato, T; Nakamura, K; Yamamoto, H; Yamamoto, T; Yuyama, K | 1 |
| Hiramoto, K; Kato, T; Kikugawa, K | 1 |
| Chakravarty, AR; Mahadevan, S; Neelakanta, G; Nethaji, M; Reddy, PA; Santra, BK | 1 |
| Arroyo, A; Daftary, A; Gandley, RE; Harger, G; Huang, W; Hubel, CA; Jiang, J; Kagan, VE; Pitt, B; Taylor, RN; Tyurin, VA | 1 |
| Behrends, A; Grube, S; Haldar, C; Hardeland, R; Ness, H; Poeggeler, B | 1 |
| Nagaraj, RH; Oya-Ito, T; Pfahler, C; Pilch, HA; Puttaiah, S; Sayre, LM; Zhang, Y | 1 |
| Ahmad, S; Ahmed, A; Ahmed, S; Al-Ani, B; Cudmore, M; Fujisawa, T; Hewett, PW | 1 |
| Carella, AJ; Gumkowski, MJ; Lukulay, P; MacDonald, BC; Roy, MC; Shamblin, SL; Waterman, KC | 1 |
| Arbillaga, L; Azqueta, A; Cascante, M; Creppy, EE; López de Cerain, A; Pachón, G | 1 |
| Bakker, LM; Chaytor, AT; Edwards, DH; Griffith, TM | 1 |
| Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EIu; Zhdankina, AA | 1 |
| Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EY; Zhdankina, AA | 1 |
| Balen, Gde O; Budni, J; Fernandes, SC; Freitas, AE; Moretti, M; Rodrigues, AL | 1 |
| Aponte, AM; Kohr, MJ; Murphy, E; Steenbergen, C; Sun, J; Tong, G | 1 |
| Hossain, MM; Kumar, S; Mia, MR; Muhib, MH; Wadud, SA | 1 |
| Blasiak, J; Chojnacki, C; Chojnacki, J; Czubatka, A; Klupinska, G; Poplawski, T | 1 |
| Hu, Y; Li, D; Li, N; Shui, L; Wen, J; Zhang, M; Zheng, G; Zou, Y | 1 |
26 other study(ies) available for quinoxalines and ascorbic acid
| Article | Year |
|---|---|
Hydrazine and quinoxaline derivatives of aryl L-ascorbic acid analogs.
Topics: Ascorbic Acid; Chemical Phenomena; Chemistry; Hydrazines; Oxidation-Reduction; Quinoxalines | 1978 |
[The effect of Mecadox on the immune response and on various chicken lymphatic organs].
Topics: Adrenal Glands; Animals; Antibody Formation; Antigens, Bacterial; Ascorbic Acid; Bursa of Fabricius; Carbadox; Chickens; DNA; Escherichia coli; Glycogen; Immunization; Nitrogen; Proteins; Quinoxalines; RNA; Thymus Gland | 1976 |
[Effect of Mecadox therapy on various organs of the reticulohistiocytary system in chickens].
Topics: Adrenal Glands; Animals; Ascorbic Acid; Bursa of Fabricius; Carbadox; Chickens; DNA; Mononuclear Phagocyte System; Nitrogen; Organ Size; Proteins; Quinoxalines; RNA; Stimulation, Chemical; Thymus Gland; Time Factors | 1976 |
Effect of dietary supplementation with vitamin C or carbadox on weanling pigs subjected to crowding stress.
Topics: Animals; Ascorbic Acid; Body Weight; Carbadox; Crowding; Leukocyte Count; Organ Size; Quinoxalines; Stress, Physiological; Swine | 1987 |
Whole blood ascorbic acid levels in chickens with experimental aplastic anemia and the effect of supplemental ascorbic acid, B 12, and minerals on mortality and pathologic manifestations.
Topics: Anemia, Aplastic; Animal Feed; Animals; Ascorbic Acid; Blood Volume Determination; Chickens; Copper; Hemorrhage; Iron; Poultry Diseases; Quinoxalines; Vitamin B 12 | 1970 |
Responses of weanling pigs to dietary supplementation with vitamin C or carbadox.
Topics: Animals; Ascorbic Acid; Body Weight; Carbadox; Ceruloplasmin; Eating; Food, Fortified; Iron; Quinoxalines; Swine; Weaning | 1984 |
nMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase.
Topics: 2-Amino-5-phosphonovalerate; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenylyl Cyclases; Animals; Ascorbic Acid; Calcium; Calmodulin; Cell Membrane; Colforsin; Cyclic AMP; Deoxyadenosines; Dopamine; Enzyme Activation; Evoked Potentials; Glycine; Hippocampus; In Vitro Techniques; Isoproterenol; Kinetics; Models, Neurological; N-Methylaspartate; Pyramidal Tracts; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Theophylline; Trifluoperazine | 1993 |
[Activity of enzymes of antioxidant protection and level of lipid peroxidation in intact NZW mice and mice exposed to mutagens].
Topics: Animals; Ascorbic Acid; Catalase; Cyclophosphamide; Iron; Lipid Peroxidation; Male; Mice; Mice, Inbred Strains; Mutagens; Oxidation-Reduction; Quinoxalines; Superoxide Dismutase | 1997 |
[The treatment of patients with complicated mandibular fractures using a method for the intraosseous administration of biologically active drug agents].
Topics: Anti-Infective Agents; Antioxidants; Ascorbic Acid; Combined Modality Therapy; Drug Therapy, Combination; Fracture Fixation, Internal; Fracture Healing; Heparin; Humans; Infusions, Intraosseous; Mandibular Fractures; Neostigmine; Quinoxalines; Time Factors | 1999 |
Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Survival; Cyclic GMP; Cysteine; Dibutyryl Cyclic GMP; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Glutathione; Half-Life; Kinetics; Nitric Oxide; Nitro Compounds; Oxadiazoles; PC12 Cells; Quinoxalines; Rats; Time Factors | 2000 |
Prevention of the formation of mutagenic and/or carcinogenic heterocyclic amines by food factors.
Topics: Amines; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Antioxidants; Ascorbic Acid; Cattle; Food; Free Radical Scavengers; Free Radicals; Glucose; Heterocyclic Compounds; Hot Temperature; Imidazoles; Meat; Mutagens; Pyrazines; Quinoxalines | 2000 |
Oxidative cleavage of DNA by a dipyridoquinoxaline copper(II) complex in the presence of ascorbic acid.
Topics: Ascorbic Acid; Catalysis; Copper; DNA; DNA, Superhelical; Electrochemistry; Models, Molecular; Molecular Conformation; Organometallic Compounds; Oxidation-Reduction; Quinoxalines; Structure-Activity Relationship | 2002 |
S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma.
Topics: Adult; Animals; Ascorbic Acid; Copper; Female; Humans; Mesenteric Arteries; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Oxidative Stress; Phenylephrine; Pre-Eclampsia; Pregnancy; Quinoxalines; Serum Albumin, Bovine; Vasodilation | 2005 |
Photocatalytic actions of the pesticide metabolite 2-hydroxyquinoxaline: destruction of antioxidant vitamins and biogenic amines - implications of organic redox cycling.
Topics: Amines; Antioxidants; Ascorbic Acid; Catalysis; Catecholamines; Dimerization; Dopamine; Ethanol; Free Radical Scavengers; Kynuramine; Light; Melatonin; Models, Chemical; Oxidants; Oxidation-Reduction; Oxygen; Piperazines; Quinoxalines; Serotonin; Spectrophotometry; Time Factors; Ultraviolet Rays; Vitamin E; Vitamins | 2004 |
Detection of dideoxyosone intermediates of glycation using a monoclonal antibody: characterization of major epitope structures.
Topics: Animals; Antibodies, Monoclonal; Ascorbic Acid; Dipeptides; Epitopes; Fructose; Glucose; Glycation End Products, Advanced; Glycosylation; Hemocyanins; Mice; Quinoxalines; Ribonuclease, Pancreatic; Ribose; Stereoisomerism | 2006 |
The release of nitric oxide from S-nitrosothiols promotes angiogenesis.
Topics: Animals; Ascorbic Acid; Carbazoles; Cells, Cultured; Culture Media, Serum-Free; Cyclic GMP-Dependent Protein Kinases; Dithiothreitol; Endothelial Cells; Enzyme Inhibitors; Guanylate Cyclase; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroarginine; Ornithine; Oxadiazoles; Phosphorylation; Quinoxalines; S-Nitrosothiols; Swine | 2006 |
Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
Topics: Ascorbic Acid; Aspirin; Chemistry, Pharmaceutical; Dosage Forms; Drug Packaging; Drug Stability; Drug Storage; Humidity; Kinetics; Models, Chemical; Monte Carlo Method; Predictive Value of Tests; Quinoxalines; Research Design; Technology, Pharmaceutical; Temperature | 2007 |
A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment.
Topics: Ascorbic Acid; Caco-2 Cells; DNA Damage; DNA Glycosylases; DNA-Formamidopyrimidine Glycosylase; Humans; Hypoxia; Prodrugs; Quinoxalines; Reactive Oxygen Species; Vitamin E | 2007 |
Modulation of gap-junction-dependent arterial relaxation by ascorbic acid.
Topics: Animals; Ascorbic Acid; Boron Compounds; Connexin 43; Connexins; Dose-Response Relationship, Drug; Endothelium, Vascular; Gap Junction alpha-4 Protein; Gap Junction alpha-5 Protein; Gap Junctions; Hydrazines; Iliac Artery; Indoles; Indomethacin; Male; Membrane Potentials; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Nitroprusside; Oxadiazoles; Phenylephrine; Quinoxalines; Rabbits; Vasodilation | 2007 |
[Changes of synaptoarchitecture of the retina after the light-induced damage and their correction by plant antioxidants].
Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome | 2008 |
Changes in the synaptoarchitectonics of the retina after light-induced damage and their correction with antioxidants of plant origin.
Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome | 2009 |
Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test.
Topics: Animals; Antidepressive Agents; Arginine; Ascorbic Acid; Cyclic GMP; Depression; Disease Models, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Exploratory Behavior; Female; Hindlimb Suspension; Indazoles; Mice; N-Methylaspartate; Nitric Oxide; Oxadiazoles; Piperazines; Purines; Quinoxalines; Signal Transduction; Sildenafil Citrate; Sulfones | 2011 |
Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling?
Topics: Animals; Ascorbic Acid; Carbazoles; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Guanylate Cyclase; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred C57BL; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrosation; Organ Culture Techniques; Oxadiazoles; Quinoxalines; Reperfusion Injury; Signal Transduction | 2013 |
In vitro antioxidant potential study of some synthetic quinoxalines.
Topics: Antioxidants; Ascorbic Acid; Free Radical Scavengers; Humans; In Vitro Techniques; Quinoxalines | 2012 |
Helicobacter pylori infection and antioxidants can modulate the genotoxic effects of heterocyclic amines in gastric mucosa cells.
Topics: Adult; Ascorbic Acid; Breath Tests; Carbon Isotopes; Comet Assay; DNA Damage; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Male; Melatonin; Middle Aged; Poland; Quinoxalines; Statistics, Nonparametric | 2013 |
In situ fluorogenic reaction for ratiometric fluorescent detection of alkaline phosphatase activity.
Topics: Alkaline Phosphatase; Ascorbic Acid; Fluorescent Dyes; Humans; Quinoxalines; Spectrometry, Fluorescence | 2022 |